Immuneering Corp
NASDAQ:IMRX
Immuneering Corp
Other Current Liabilities
Immuneering Corp
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Immuneering Corp
NASDAQ:IMRX
|
Other Current Liabilities
$259.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Abbvie Inc
NYSE:ABBV
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
149%
|
CAGR 5-Years
406%
|
CAGR 10-Years
26%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Liabilities
$648.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Liabilities
$516.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
23%
|
See Also
What is Immuneering Corp's Other Current Liabilities?
Other Current Liabilities
259.8k
USD
Based on the financial report for Dec 31, 2023, Immuneering Corp's Other Current Liabilities amounts to 259.8k USD.